Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
G1 Therapeutics, Inc. (GTHX) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/08/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/21/2022 SC 13G JPMORGAN CHASE & CO reports a 5% stake in G1 THERAPEUTICS, INC.
02/11/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/11/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/07/2019 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/10/2019 SC 13G WELLINGTON MANAGEMENT GROUP LLP reports a 10.1% stake in G1 Therapeutics Inc
02/13/2018 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/13/2018 SC 13G Lumira Capital Investment Management Inc. reports a 5.5% stake in G1 Therapeutics, Inc.
02/08/2018 SC 13G ASTRAZENECA PLC reports a 10.4% stake in G1 Therapeutics, Inc.
02/06/2018 SC 13G FRANKLIN RESOURCES INC reports a 5.4% stake in G1 THERAPEUTICS, INC.
12/11/2017 SC 13G FMR LLC reports a 14.5% stake in G1 THERAPEUTICS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy